Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

January 14, 2023

Study Completion Date

January 14, 2023

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

SC1011

SC1011 tablet

DRUG

Placebo tablet

SC1011-matching placebo tablet

Trial Locations (1)

Shanghai Xuhui District Central Hospital, Shanghai

All Listed Sponsors

lead

Guangzhou JOYO Pharma Co., Ltd

INDUSTRY